Jazz Pharmaceuticals, Inc. (NASDAQ: JAZZ), a specialty pharmaceutical company, focuses their efforts on identifying, developing and commercializing innovative products designed to address unmet medical needs in neurology and psychiatry. Their goal as a company is to develop a broad portfolio of products through internal development and acquisition/in-licensing while utilizing a specialty sales force to promote products in target markets. For further information, visit the Company’s web site at www.jazzpharmaceuticals.com.
- 16 years ago
QualityStocks
Jazz Pharmaceuticals, Inc. (NASDAQ: JAZZ)
Tags Rodman & Renshaw
Related Post
-
QualityStocksNewsBreaks – Better Choice Company, Inc. (NYSE American: BTTR) Completes Merger with SRx Health, Will Rebrand as SRx Health Solutions Inc.
Better Choice Company (NYSE American: BTTR) announced the closing of its business combination with SRx…
-
Brera Holdings PLC’s (NASDAQ: BREA) S.S. Juve Stabia S.r.l Posts Largest Valuation Percentage Gain; Signals Club’s Growing Competitiveness
Brera Holdings, an Ireland-based, international holding company focused on expanding its global portfolio of men’s…
-
QualityStocksNewsBreaks – Soligenix Inc. (NASDAQ: SNGX) Moves Forward to Strengthen the Case for HyBryte(TM)
Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company, is advancing its phase 3 replication study (“FLASH2”)…